Omkar Kawalekar

Cell & Gene Therapy Manufacturing: Critical Challenges, Innovative Responses

Cell & Gene Therapy / Deloitte’s Omkar Kawalekar, Hussain Mooraj, and Amit Agarwal examine the evolution and future of cell and gene therapy manufacturing and the areas in which biopharma firms need to invest in order to succeed in this emergent field.   Cell and gene therapies (CGT) are the next evolution of personalized health care. These products are potentially…